The Future of Point-of-care Testing in Latin America

As Latin America (LATAM) experiences a shift towards decentralised IVD testing and greater constraints on fiscal budgets and healthcare systems, IVD companies will have to adapt their market strategy to meet the region’s increased demand for affordable point-of-care (POC) tests, particularly around infectious diseases.EIU Healthcare latest report explores how the region is tackling infectious disease impact through decentralised diagnostics.

Download free report

The Future of Pathology: Four Growth Areas in Tissue Diagnostics (TDx)

Download EIU Healthcare’s latest infographic for insights into four growth areas central to the future of pathology.

Download infographic

forecast article

LATAM IVD market to grow 2.8 per cent annually between 2019 to 2024

The Latin America in-vitro diagnostics (IVD) market is expected to recover in 2024 after government measures to mitigate the worsening socioeconomic crisis amidst the Covid-19 pandemic.

Learn more

FORECAST ARTICLE

APAC IVD market to grow 4.4 per cent annually between 2019 to 2024

The Asia-Pacific in-vitro diagnostics (IVD) market will continue to see key trends in hospital and patient care, government policies which will drive up overall diagnosis needs, and fuel fast growth for certain market segments.

Learn more

EIU Gateway: Track IVD Market Size, Share and Trends

EIU IVD Gateway is the definitive source for In-Vitro Diagnostics data for each of the major IVD segments across 36 countries and territories. We deliver robust and up-to-date analysis, forecasts and insights to help shape your business strategies. Find out more and book a demo today.

Find out more